
Varian Medical Systems
Overview
Leading manufacturer of medical devices and software for cancer treatment.
Founded
1948
Deals ยท 12mo
0
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
HistoSonics | Jun 2020Participated | $40 MSeries C | |
Arterys | May 2020Participated | $28 MSeries C | |
Zap Surgical Systems | Jan 2020Participated | $81 MOther Equity | |
Oncora Medical | Oct 2019Led | $3 MOther Equity | |
HistoSonics | Apr 2019Led | $54 MSeries C | |
ABK Biomedical | Apr 2019Led | $30 MSeries B | |
Fusion Pharmaceuticals | Apr 2019Led | $105 MSeries B | |
Fusion | Apr 2019Led | $105 MSeries B | |
Berkeley Lights | Oct 2018Participated | $95 MOther Equity | |
Arterys | Nov 2017Participated | $30 MSeries B | |
Fusion Pharmaceuticals | Sep 2017Participated | $21 MSeries A | |
HistoSonics | Jun 2020Participated | $40 MSeries C | |
Arterys | May 2020Participated | $28 MSeries C | |
Zap Surgical Systems | Jan 2020Participated | $81 MOther Equity | |
Oncora Medical | Oct 2019Led | $3 MOther Equity | |
HistoSonics | Apr 2019Led | $54 MSeries C | |
ABK Biomedical | Apr 2019Led | $30 MSeries B | |
Fusion Pharmaceuticals | Apr 2019Led | $105 MSeries B | |
Fusion | Apr 2019Led | $105 MSeries B | |
Berkeley Lights | Oct 2018Participated | $95 MOther Equity | |
Arterys | Nov 2017Participated | $30 MSeries B | |
Fusion Pharmaceuticals | Sep 2017Participated | $21 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 1 |
| Series B | 3 | 1 |
| Series C+ | 1 | 2 |
| Other Equity | 1 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '17 | 1 |
| Oct '17 | 0 |
| Nov '17 | 1 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 1 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 4 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 1 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 1 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 1 |
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 11 |
| Enterprise Software | 3 |
| Marketing & Advertising | 1 |
| Manufacturing | 1 |
| Media & Entertainment | 1 |
| AI & Machine Learning | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 4 |
| $50M-$100M | 3 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 8 |
| Canada | 3 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Johnson & Johnson Innovation | 5 |
| Adams Street Partners | 3 |
| FACIT | 3 |
| Genesys Capital | 3 |
| HealthCap | 3 |
| Seroba Life Sciences | 3 |
| TPG Biotech | 3 |
| Emergent Medical Partners | 2 |
| Fosun | 2 |
| Lumira Ventures | 2 |
| OrbiMed | 2 |
| Perceptive Advisors | 2 |
| Pivotal bioVenture Partners | 2 |
| Rock Springs Capital | 2 |
| ShangBay Capital | 2 |
| State of Wisconsin Investment Board | 2 |
| Venture Investors | 2 |
| AJS BioTree Healthcare Fund | 1 |
| Atinum Investment | 1 |
| Benslie International Fund | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 45% |
| Participating | 6 | 55% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 40% |
| Co-led | 3 | 60% |
Team
Director, Strategic Alliances
Commercial Strategy Lead
Director, Marketing & Strategy, Medical Oncology Software
President and Chief Executive Officer
Co-Founder
VP and Chief Information Security Officer
Senior Vice President, Chief Legal Officer
Vice President, Corporate Communications and Investor Relations
Co-Founder